Skip to main content

Hepatotoxicity in Patients with Liver Disease

  • Conference paper
Toxicological Aspects of Food Safety

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 1))

Abstract

The biochemical and physiological disturbances caused by liver disease may enhance the toxicity of drugs.

Besides alterations in liver blood flow and drug binding, a decreased rate of drug metabolism is an important phenomenon. Studies with phenazone, a model drug, demonstrates that the rate of microsomal drug metabolism is related to the degree of metabolic hepatic impairment.

Individual dosage adjustments in patients with liver disease are complicated for many drugs, because of the counteracting influences of a decreased hepatic blood clearance and an increased free fraction of drug which may enhance drug metabolism and drug action.

Moreover, many drugs owe part of their pharmacological action to active metabolites formed in the liver. Finally, little is known about altered receptor sensitivity in patients with liver disease.

Non-predictable hepatotoxic reactions appear not to occur more frequently in patients with liver disease than in other patients. However, hepatotoxicity may be masked by the liver disease or by the intake of ethanol.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Andreasen, P.B., Greisen, G.: European Journal of Clinical Investigation 6, 21 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Andreasen, P.B., Ranek, L.: Scandinavian Journal of Gastroenterology 10, 293 (1975)

    PubMed  CAS  Google Scholar 

  • Andreasen, P.B., Ranek, L., Statland, B.E., Tygstrup, N.: European Journal of Clinical Investigation 4, 129 (1974)

    PubMed  CAS  Google Scholar 

  • Andreasen, P.B., Hendel, J., Greisen, G., Hvidberg, E.F.: European Journal of Clinical Pharmacology 10, 115 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Blaschke, T.F.: Clinical Pharmacokinetics 2, 32 (1977)

    Article  PubMed  CAS  Google Scholar 

  • Held, H., Eisert, R., von Olderhausen, H.F.: Arzneimittelforschung 23, 1801 (1973)

    PubMed  CAS  Google Scholar 

  • Hendel, J., Elsass, P., Andreasen, P.B., Gymoese, E., Hvidberg, E.F.: Psychopharmacology 48, 11 (1976)

    Article  PubMed  CAS  Google Scholar 

  • Klotz, U., Avant, G.R., Hoyumpa, A., Schenker, S., Wilkinson, G.R.: Journal of Clinical Investigation 55, 347 (1975)

    Article  PubMed  CAS  Google Scholar 

  • Mitchell, J.R., Thorgeirsson, S.S., Potter, W.Z., Jollow, D.J., Keiser, H.: Clinical Pharmacology and Therapeutics 16, 676 (1974)

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag

About this paper

Cite this paper

Andreasen, P.B. (1978). Hepatotoxicity in Patients with Liver Disease. In: Leonard, B.J. (eds) Toxicological Aspects of Food Safety. Archives of Toxicology, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66896-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66896-8_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-08646-8

  • Online ISBN: 978-3-642-66896-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics